Evropská unie - finština - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiset aineet - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Evropská unie - finština - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfooma, mantle-cell - antineoplastiset aineet - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Finsko - finština - Fimea (Suomen lääkevirasto)

orion corporation - methotrexate - injektioneste, liuos, esitäytetty ruisku - 25 mg/ml - metotreksaatti

Finsko - finština - Fimea (Suomen lääkevirasto)

orion corporation - methotrexate disodium - tabletti - 2.5 mg - metotreksaatti

Finsko - finština - Fimea (Suomen lääkevirasto)

orion corporation - methotrexate disodium - tabletti - 10 mg - metotreksaatti

Evropská unie - finština - EMA (European Medicines Agency)

mitsubishi pharma europe ltd - kolestilaani - hyperphosphatemia - hyperkalaemian ja hyperfosfatemian hoitoon tarkoitetut lääkkeet - hyperfosfatemian hoito aikuispotilailla, joilla on krooninen munuaissairaus vaiheessa 5, jotka saivat hemodialyysiä tai peritoneaalidialyysiä.

Finsko - finština - Fimea (Suomen lääkevirasto)

essential pharma (m) ltd - carbamazepine - peräpuikko - 250 mg - karbamatsepiini

Finsko - finština - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - lamotrigine - purutabletti/dispergoituva tabletti - 5 mg - lamotrigiini

Finsko - finština - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - lamotrigine - purutabletti/dispergoituva tabletti - 25 mg - lamotrigiini

Finsko - finština - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - lamotrigine - purutabletti/dispergoituva tabletti - 50 mg - lamotrigiini